These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8996606)

  • 1. Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II.
    Beck WT; Danks MK; Wolverton JS; Chen M; Granzen B; Kim R; Suttle DP
    Adv Pharmacol; 1994; 29B():145-69. PubMed ID: 8996606
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
    Solary E; Bertrand R; Pommier Y
    Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerases in human leukemia.
    Peereboom D; Charron M; Kaufmann SH
    Adv Pharmacol; 1994; 29B():33-50. PubMed ID: 8996600
    [No Abstract]   [Full Text] [Related]  

  • 4. Topoisomerase enzymes as drug targets.
    Guichard SM; Danks MK
    Curr Opin Oncol; 1999 Nov; 11(6):482-9. PubMed ID: 10550012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast as a genetic model system for studying topoisomerase inhibitors.
    Nitiss JL
    Adv Pharmacol; 1994; 29B():201-26. PubMed ID: 8996609
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA topoisomerases and radiation responses.
    Smith PJ
    Int J Radiat Biol; 1990 Oct; 58(4):553-9. PubMed ID: 1976716
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
    Stevnsner T; Bohr VA
    Carcinogenesis; 1993 Sep; 14(9):1841-50. PubMed ID: 8403208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of DNA topoisomerases in UV-induced DNA excision repair: studies with specific inhibitors in permeabilized human fibroblasts.
    Popanda O; Thielmann HW
    Carcinogenesis; 1992 Dec; 13(12):2321-8. PubMed ID: 1335377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-topoisomerase I and II: biologic features and their role in drug resistance.
    Russo D; Marie JP; Delmer A; Zhou D; Suberville AM; Baccarani M; Zittoun R
    Haematologica; 1993; 78(4):201-7. PubMed ID: 8294050
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
    Beck WT; Danks MK
    Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases.
    Hickson ID; Davies SL; Davies SM; Robson CN
    Int J Radiat Biol; 1990 Oct; 58(4):561-8. PubMed ID: 1976717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of cellular sensitivity to topoisomerase-targeting antitumor drugs.
    D'Arpa P
    Adv Pharmacol; 1994; 29B():127-43. PubMed ID: 8996605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance associated with altered DNA topoisomerase II.
    Beck WT; Danks MK; Wolverton JS; Kim R; Chen M
    Adv Enzyme Regul; 1993; 33():113-27. PubMed ID: 8395133
    [No Abstract]   [Full Text] [Related]  

  • 14. From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives.
    Finlay GJ; Riou JF; Baguley BC
    Eur J Cancer; 1996 Apr; 32A(4):708-14. PubMed ID: 8695277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA topoisomerase II mutations and resistance to anti-tumor drugs.
    Vassetzky YS; Alghisi GC; Gasser SM
    Bioessays; 1995 Sep; 17(9):767-74. PubMed ID: 8763829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
    Furukawa M; Harada T; Tanaka T; Kuwano M
    Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage T4, a model system for understanding the mechanism of type II topoisomerase inhibitors.
    Kreuzer KN
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):339-47. PubMed ID: 9748648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerases as targets for cancer therapy.
    Ross WE
    Biochem Pharmacol; 1985 Dec; 34(24):4191-5. PubMed ID: 3000380
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor activity of XR5944, a novel and potent topoisomerase poison.
    Stewart AJ; Mistry P; Dangerfield W; Bootle D; Baker M; Kofler B; Okiji S; Baguley BC; Denny WA; Charlton PA
    Anticancer Drugs; 2001 Apr; 12(4):359-67. PubMed ID: 11335793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription. Gene expression needs a break to unwind before carrying on.
    Haince JF; Rouleau M; Poirier GG
    Science; 2006 Jun; 312(5781):1752-3. PubMed ID: 16794066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.